Content Topics

Climate 73

View All

Deep Tech Opportunities Report

DCVC DTOR 2025: We must get better at managing methane

Deep Tech Opportunities Report

DCVC DTOR 2025: The increasing volatility of electrical supply and demand means it’s time to invest more in grid-stabilizing technologies

Radiant raises $300 million+ Series D toward portable nuclear energy at scale

By Dr. Rachel Slaybaugh

Deep Tech Opportunities Report

DCVC DTOR 2025: One way to stop adding carbon to the air is to get the carbon we need from the air

Computational Bio & Chem 28

View All

Company Profile

Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits

By Dr. Emily Park, Dr. Kiersten Stead

Latus Bio finds a better way to deliver genes to cells deep in the brain to help patients with neurodegeneration

By Dr. Kiersten Stead

Creyon Bio deal with Lilly brings up to $1 billion in payments for research on RNA-targeting drugs

By Dr. Kiersten Stead

Manufacturing cancer-killing T cells inside the body

By Dr. John Hamer, Dr. Kiersten Stead

Cybersecurity, Security, & Defense 17

View All

How Fortem is helping the U.S. and its allies get ahead of the drone threat

By Matthew Ocko, Matt O'Connell

Human identity needs a Zero Trust moment

Reality Defender democratizes deepfake detection with public API launch

Reality Defender answers FINRA call

Enterprise Enablement 5

View All

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC companies are at the forefront of better generative AI: Databricks to acquire MosaicML for $1.3B

By Matthew Ocko

Element AI raises $151M Series B to enable artificial intelligence at the heart of every company

By Matthew Ocko, Zachary Bogue

DCVC Portfolio IPO: Elastic goes public, opening at a $4.4 billion valuation

By Matthew Ocko, Zachary Bogue

Finance & Insurance 4

View All

A new precision power market

DCVC proud to back ElectronX in its quest to build the first-ever direct-access regulated derivatives exchange for the electric power markets

Deep Tech Opportunities Report

Cryptography for the real world

StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain

By Matthew Ocko

Foundational Technology 12

View All

Quantum’s super position

By Matthew Ocko, James Hardiman, Dr. Prineha Narang

Mythic raises $125M to break through AI’s power wall

By Matthew Ocko

Deep Tech Opportunities Report

DCVC DTOR 2025: America needs exponentially greater computing power, in more locations, using less electricity

Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership

By Matthew Ocko, Zachary Bogue

Industrial Transformation 33

View All

Deep Tech Opportunities Report

DCVC DTOR 2025: Robots should be backward-compatible with the real world

Fulfil’s robot revolution comes to Whole Foods

Company Profile

Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy

Deep Tech Opportunities Report

DCVC DTOR 25: Deep tech will solidify the United States’ advantage as a global manufacturing powerhouse while sparing the environment

Smart Agriculture 16

View All

Halter’s invisible fencing drives an inevitable shift in ranching

By Spencer Punter

Company Profile

Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners

By Dr. Justin Kern

Deep Tech Opportunities Report

DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now

CH4 Global opens the world's first commercial-scale Asparagopsis production facility

By Zachary Bogue, Dr. Justin Kern

Space 9

View All

DCVC anchors $150 million in financing for Impulse Space to deliver precise, fast, and affordable maneuverability of satellites within and between orbits

By Matthew Ocko, Matt O'Connell

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC Announcements

DCVC Welcomes 2022

On Going to Space

TechBio 9

View All

Proxima raises $80M in seed financing, led by DCVC, to reprogram protein-protein interactions

By Jason Pontin

Noetik’s partnership with GSK puts dollar signs on the AI licensing business model in TechBio

By James Hardiman

Company Profile

Why Kanvas built its own production line for microbiome therapeutics

By Jason Pontin

Relation unveils atopic diseases agreement with Novartis—$55 million up front and up to $1.7 billion in milestone-based payments; DCVC, NVIDIA NVentures, and Magnetic Ventures co-lead $26M fundraise

By Jason Pontin, Zachary Bogue

TechMed 22

View All

Remedy’s AI-powered robot supports world’s first remote neurointervention

By James Hardiman

Proprio’s latest FDA approval clears the way for better, AI-driven surgery

Proprio's Physical AI at the 2025 JPM Healthcare Conference

The Somatic AI revolution: How TechMed is reshaping healthcare as we know it